Management of May Thurner Syndrome in Pregnant Patients.

May Thurner Syndrome contributes to thromboembolic disease and can cause significant morbidity in pregnant patients secondary to exaggerated anatomic relationships and physiologic changes in the hematologic system favoring thrombogenesis. Because this condition is both underrecognized and underreported, management in pregnant and postpartum patients is based on expert opinion without any formal evidence-based guidance. Herein, we review five pregnancies in four patients with May Thurner Syndrome and general management strategies.

Challenges in Pathology Specimen Processing in the New Era of Precision Medicine.

Context.—: Precision therapies for patients with driver mutations can offer deep and durable responses that correlate with diagnosis, metastasis prognosis, and improvement in survival. The use of such targeted therapies will continue to increase, pushing us to change our traditional approaches.

Proactive and Reactive Aggressive Behaviors: Dimensionality of Self-Report Scales.

The literature distinguishes aggressive behavior as being either proactive or reactive; however, despite being highly comorbid, they appear to possess unique correlation patterns to external variables. We propose to assess the dimensionality and latent profiles that emerged based on the Peer Aggressive Behavior Scale (PAB-S) and the Peer Aggressive and Reactive Behavior Questionnaire (PARB-Q). Confirmatory Factor Analysis (CFA) and Latent Profile Analysis (LPA) was conducted on two self-report scales in a non-representative Brazilian sample composed by 2,517 students of elementary school (1,275 girls; 50.

Safety and Efficacy of Acute Pulmonary Embolism Treated via Large-Bore Aspiration Mechanical Thrombectomy Using the Inari FlowTriever Device.

Purpose: To report initial experience with safety and efficacy in the treatment of pulmonary embolism (PE) using the FlowTriever device.

Materials And Methods: A single-center retrospective study was performed in all patients with acute central PE treated using the FlowTriever device between March 2018 and March 2019. A total of 46 patients were identified (massive = 8; submassive = 38), all with right ventricular (RV) strain and 26% with thrombolytic contraindications.